Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077311
Status:
COMPLETED
Last Update Posted:
2016-06-30
First Post:
2004-02-10
Brief Title:
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neutropenia |
| DrugAgent Toxicity by TissueOrgan |
| Lung Cancer |
| Anemia |
Keywords:
| Name | View |
|---|---|
| anemia | View |
| neutropenia | View |
| stage IV non-small cell lung cancer | View |
| stage IIIB non-small cell lung cancer | View |
| squamous cell lung cancer | View |
| large cell lung cancer | View |
| adenocarcinoma of the lung | View |
| adenosquamous cell lung cancer | View |
| drugagent toxicity by tissueorgan | View |
| recurrent non-small cell lung cancer | View |
| bronchoalveolar cell lung cancer | View |